13th International Congress
13th International Congress

The 13th International Congress Continuing Medical Education

June 7-11, 2009
Palais Des Congrès de Paris
Paris, France

Continuing Medical Education Information

Purpose
The purpose of the MDS International Congress is to offer a forum for clinical and basic discussion on a variety of Movement Disorder topics, including presentations of current research and available treatments.

Learning Objectives
Through state-of-the-art lectures, hot topic reviews, controversy debates, Teaching Courses, How To Do It - Skills Workshops and Video Sessions, participants will be better able to:

  1. Describe the pathophysiology and neurobiology of Parkinson’s disease and other Movement Disorders;
  2. Discuss the diagnostic approaches and tools available for Parkinson’s disease and other Movement Disorders;
  3. Discuss the pharmacological and non-pharmacological treatment options available for Parkinson’s disease and other Movement Disorders.

Continuing Medical Education
The Movement Disorder Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
CME Credit

The Movement Disorder Society designates this educational activity for a maximum of 30.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPD Credit
The Royal College of Physicians designates this educational activity for a maximum of 29 CPD credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Claiming CME Credits or Certificates of Attendance
To claim your CME Credit or Certificates of Attendance, please follow the link below to fill out the Online CME Self-Report Form and print your CME Certificate or Certificate of Attendance from your computer.

Target Audience
The target audience of the 13th International Congress of Parkinson’s Disease and Movement Disorders includes clinicians, researchers, post-doctoral fellows, medical residents, medical students and other healthcare professionals with an interest in the current research and approaches for the diagnosis and treatment of Movement Disorders.

Faculty Financial Disclosure Information
It is the policy of The Movement Disorder Society (MDS) to ensure balance, independence, objectivity, and scientific rigor in all MDS sponsored educational activities. All persons in control of content in any MDS sponsored activity are required to disclose to MDS and the activity audience all financial relationships with any commercial interest. Such persons include, but are not limited to: planning committee members, faculty, medical writers, joint sponsor staff (when applicable), co sponsor staff (when applicable) and MDS staff.

Relationships are defined as financial relationships in any amount occurring within the past 12 months from the signing date of the attestation. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the field of Movement Disorders. This disclosure will be provided to all participants prior to the beginning of the CME activity. Individuals must inform MDS of any changes in financial relationships that occur between the signing date of the attestation and the date of the activity. For an individual with no financial relationships to disclose, the learners must be informed that no financial relationships exist.

The intent of this policy is not to prevent a speaker with a conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified and resolved prior to the activity, so that there is no commercial bias present in the presentation. Failure by any faculty or planning committee member to disclose all such relationships will result in their inability to participate in the CME activity.

Faculty financial disclosure information will be provided to participants onsite in Paris.